 |
 |
Cellmate
has been installed in over 80 sites around
the world for batch production of biologics
(protein therapeutics and vaccines), process
development and research. Cellmate allows
the same, simple, flask-based (T flasks
and roller bottles) manual culture processes
to be scaled up from research to production
without process change shortening development
times, reducing infrastructure requirements
and simplifying validation for products
that are difficult or impractical to transition
in to large scale bioreactor production.
|
| |
- Merck
chose Cellmate for production of their
FDA approved varicella vaccine, Varivax
- Novartis
Animal Health chose Cellmate
to automate the production of a range
of animal vaccines
- Baxter
Vaccines chose Cellmate for the
production of a new generation of cell
culture produced influenza vaccine
|
| |
For more information
visit: Cellmate
- system overview |
| |
For
more information on TAP's products and key
applications: |
| |
View the
full range of TAP
key application areas |
| |
Learn more
about TAP's product range -
the TAP Interactive Product Selector |
| |
Discuss
your requirements with Ian
Ransome, Sales Director |
| |
|
